PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
1-Year Return
21.39%
This Quarter Return
+0.32%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$1.83B
AUM Growth
-$176M
(-8.7%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
48.51%
Holding
93
New
6
Increased
23
Reduced
12
Closed
14
Top Buys
| 1 |
UnitedHealth
UNH
|
$25.5M |
| 2 |
Amgen
AMGN
|
$25.3M |
| 3 |
Stryker
SYK
|
$20.1M |
| 4 |
Johnson & Johnson
JNJ
|
$18.8M |
| 5 |
Insmed
INSM
|
$16.2M |
Top Sells
| 1 |
Legend Biotech
LEGN
|
$41.2M |
| 2 |
Zimmer Biomet
ZBH
|
$39.6M |
| 3 |
Avantor
AVTR
|
$34.3M |
| 4 |
Veeva Systems
VEEV
|
$27.5M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$20.8M |
Sector Composition
| 1 | Healthcare | 97.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Astria Therapeutics
ATXS
$369M
| – | – |
-327,045
| Closed | -$4.6M |
|
|
77
Avantor
AVTR
$8.76B
| – | – |
-1,343,309
| Closed | -$34.3M |
|
|
BLUE
78
DELISTED
bluebird bio
BLUE
| – | – |
-102,133
| Closed | -$2.61M |
|
|
79
iShares Russell 2000 ETF
IWM
$66.8B
| – | – |
-99,115
| Closed | -$20.8M |
|
|
80
Legend Biotech
LEGN
$6.44B
| – | – |
-734,293
| Closed | -$41.2M |
|
81
Invesco QQQ Trust
QQQ
$365B
| – | – |
0
| – | – |
|
82
iShares 20+ Year Treasury Bond ETF
TLT
$47.8B
| – | – |
0
| – | – |
|
|
83
Veeva Systems
VEEV
$43.7B
| – | – |
-118,905
| Closed | -$27.5M |
|
84
West Pharmaceutical
WST
$17.9B
| – | – |
-51,197
| Closed | -$20.3M |
|
85
SPDR S&P Biotech ETF
XBI
$5.26B
| – | – |
0
| – | – |
|
|
86
Zimmer Biomet
ZBH
$20.7B
| – | – |
-300,351
| Closed | -$39.6M |
|
|
SILK
87
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| – | – |
-331,064
| Closed | -$6.07M |
|
|
INBX
88
DELISTED
Inhibrx, Inc. Common Stock
INBX
| – | – |
-47,918
| Closed | -$1.68M |
|